SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-244360
Filing Date
2018-08-09
Accepted
2018-08-09 16:21:13
Documents
57
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d638585d10q.htm 10-Q 817150
2 EX-31.1 d638585dex311.htm EX-31.1 6422
3 EX-31.2 d638585dex312.htm EX-31.2 6409
4 EX-32.1 d638585dex321.htm EX-32.1 4762
  Complete submission text file 0001193125-18-244360.txt   3263144

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mgta-20180630.xml EX-101.INS 373742
6 XBRL TAXONOMY EXTENSION SCHEMA mgta-20180630.xsd EX-101.SCH 37290
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mgta-20180630_cal.xml EX-101.CAL 48712
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mgta-20180630_def.xml EX-101.DEF 240979
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mgta-20180630_lab.xml EX-101.LAB 314423
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mgta-20180630_pre.xml EX-101.PRE 276624
Mailing Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Filer) CIK: 0001690585 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38541 | Film No.: 181005347
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences